계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Sciwind Biosciences
company
About
Sciwind Biosciences is a drug research and development company for metabolic diseases.
- 51 - 100
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- ¥450M
- Industries
- Biotechnology,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2017
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Sciwind Biosciences is a developers of drugs intended to treat metabolic disorders. The company's drugs contain protein and peptide candidates for non-alcoholic steatohepatitis, enabling physicians to treat their patients in an enhanced way.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥450M
Sciwind Biosciences has raised a total of
¥450M
in funding over 2 rounds. Their latest funding was raised on
Oct 11, 2021 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 11, 2021 | Series C | ¥450M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Sciwind Biosciences is funded by 1 investors.
Zhengxingu Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
